UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 28, 2005
DATIGEN.COM, INC.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Utah 0-26027 87-0626333
- ---------------------------- ----------- -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
c/o David Lubin & Associates
92 Washington Avenue
Cedarhurst, NY 11516
(Address of principal executive offices)
(516) 569-9629
(Registrant's telephone number, including
area code)
--------------------------------------------------------------
(Former name or former address, if changed since last report.)
Section 1- Registrant's Business and Operations
Item 1.01 Entry into a Material Definitive Agreement
As previously disclosed in the Current Report on Form 8-K filed by Datigen.com,
Inc. (the "Registrant") on December 17, 2004 (File No. 000-26027), the
Registrant entered into a binding letter of intent with Purisys, Inc., a New
Jersey corporation, and the sole shareholder of Purisys, which provides, among
other things, for the sale to the Registrant of all of the assets constituting
the Battery Brain Product owned by Purisys. On February 28, 2005, the Registrant
and Purisys amended the Letter of Intent to provide that the Registrant advanced
an additional $170,000 to Purisys to cover day-to-day operations, finalize the
purchase of 5,000 retail package units and commence the purchase of 5,000
wholesale package units. These units and all rights associated with these units,
including without limitation, revenues from the sales of these units, will be
part of the assets to be purchased by the Registrant. The sum of $170,000, plus
the previous amount of $120,000 paid to Purisys pursuant to the Letter of
Intent, shall reduce the $1,000,000 equity investment required in the Registrant
at the time of closing the transaction between the parties.
For all the terms and conditions of the letter extending the Letter of Intent,
reference is hereby made to such agreement annexed hereto as Exhibit 10.2. All
statements made herein concerning the foregoing agreement are qualified by
references to said exhibit.
Section 9-Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
(a) Financial Information. Not applicable
(b) Pro forma financial information. Not applicable
(c) Exhibits Exhibit
10.2 Letter dated February 28, 2005 between Purisys, Inc. and the
Registrant
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DATIGEN.COM, INC.
(Registrant)
By: /s/ Amir Uziel
---------------------------------
President and Chief Executive Officer
Date: March 1, 2005
-3-